Literature DB >> 31582186

Update and review of adult polycystic kidney disease.

Gates B Colbert1, Mohamed E Elrggal2, Lovy Gaur3, Edgar V Lerma4.   

Abstract

Autosomal dominant polycystic kidney disease is a common cause of end stage kidney disease. It is a progressive and unfortunately incurable condition that can lead to significant morbidity and kidney failure. Many more patients are diagnosed with this disease without any symptoms as the population is increasingly undergoing imaging for other problems and diagnostic workup. Our understanding of the genetic variants has increased in recent years as research continues to improve. As well, therapeutic options have developed with the FDA approval of a new treatment medication, with many others underway. This review updates the clinician on the pathophysiology, clinical aspects, and therapeutic options for patients the is form of kidney disease.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autosomal dominant kidney disease; End stage kidney disease; Hypertension; Kidney cyst; Tolvaptan

Mesh:

Year:  2019        PMID: 31582186     DOI: 10.1016/j.disamonth.2019.100887

Source DB:  PubMed          Journal:  Dis Mon        ISSN: 0011-5029            Impact factor:   3.800


  6 in total

Review 1.  Polycystins as components of large multiprotein complexes of polycystin interactors.

Authors:  Emily Hardy; Leonidas Tsiokas
Journal:  Cell Signal       Date:  2020-04-17       Impact factor: 4.315

Review 2.  Autosomal dominant polycystic kidney disease and pioglitazone for its therapy: a comprehensive review with an emphasis on the molecular pathogenesis and pharmacological aspects.

Authors:  Aryendu Kumar Saini; Rakesh Saini; Shubham Singh
Journal:  Mol Med       Date:  2020-12-11       Impact factor: 6.354

3.  Demographic, diagnostic and therapeutic characteristics of autosomal dominant polycystic kidney disease in Ghana.

Authors:  Perditer Okyere; Richard K D Ephraim; Isaac Okyere; Joseph Attakorah; Dorcas Serwaa; Grace Essuman; Albert Abaka-Yawson; Prince Adoba
Journal:  BMC Nephrol       Date:  2021-04-28       Impact factor: 2.388

4.  Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options.

Authors:  Yeshwanter Radhakrishnan; Parikshit Duriseti; Fouad T Chebib
Journal:  Kidney Res Clin Pract       Date:  2022-03-29

5.  Predicting the number of citations of polycystic kidney disease with 100 top-cited articles since 2010: Bibliometric analysis.

Authors:  Chen-Yu Wang; Tsair-Wei Chien; Willy Chou; Hsien-Yi Wang
Journal:  Medicine (Baltimore)       Date:  2022-09-23       Impact factor: 1.817

6.  Spontaneous Polycystic Kidneys with Chronic Renal Failure in an Aged House Musk Shrew (Suncus murinus).

Authors:  Tohru Kimura
Journal:  Vet Sci       Date:  2022-03-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.